BG104122A - 2-{3-[4-(2-tret.-butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1 -yl]propylmercapto}pyrimidin-4-ol fumarate - Google Patents
2-{3-[4-(2-tret.-butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1 -yl]propylmercapto}pyrimidin-4-ol fumarateInfo
- Publication number
- BG104122A BG104122A BG104122A BG10412200A BG104122A BG 104122 A BG104122 A BG 104122A BG 104122 A BG104122 A BG 104122A BG 10412200 A BG10412200 A BG 10412200A BG 104122 A BG104122 A BG 104122A
- Authority
- BG
- Bulgaria
- Prior art keywords
- propylmercapto
- trifluoromethylpyrimidin
- tret
- piperazin
- pyrimidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19735410A DE19735410A1 (de) | 1997-08-14 | 1997-08-14 | 2-{3-[4-(2-t-Butyl-6-trifluormethylpyrimidin-4-yl)piperazin-1-yl]propylmercapto}pyrimidin-4-ol-fumarat |
| PCT/EP1998/005178 WO1999009015A1 (de) | 1997-08-14 | 1998-08-14 | 2-{3-[4-(2-t-butyl-6- trifluormethylpyrimidin-4-yl) piperrazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG104122A true BG104122A (en) | 2000-11-30 |
Family
ID=7839072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG104122A BG104122A (en) | 1997-08-14 | 2000-02-03 | 2-{3-[4-(2-tret.-butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1 -yl]propylmercapto}pyrimidin-4-ol fumarate |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20010020022A1 (ko) |
| EP (2) | EP1003728B1 (ko) |
| JP (1) | JP4444492B2 (ko) |
| KR (1) | KR100571945B1 (ko) |
| CN (1) | CN1267286A (ko) |
| AR (1) | AR016605A1 (ko) |
| AT (1) | ATE525362T1 (ko) |
| AU (1) | AU749575B2 (ko) |
| BG (1) | BG104122A (ko) |
| BR (1) | BR9811177A (ko) |
| CA (1) | CA2301297A1 (ko) |
| CO (1) | CO4960663A1 (ko) |
| DE (1) | DE19735410A1 (ko) |
| ES (1) | ES2374156T3 (ko) |
| HU (1) | HUP0003710A3 (ko) |
| ID (1) | ID24639A (ko) |
| IL (1) | IL134246A (ko) |
| NO (1) | NO314935B1 (ko) |
| NZ (1) | NZ502675A (ko) |
| PL (1) | PL201927B1 (ko) |
| SK (1) | SK1182000A3 (ko) |
| TR (1) | TR200000406T2 (ko) |
| TW (1) | TW467912B (ko) |
| WO (1) | WO1999009015A1 (ko) |
| ZA (1) | ZA987239B (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2311012T3 (es) * | 2000-03-27 | 2009-02-01 | ABBOTT GMBH & CO. KG | Ligandos del receptor d3 de la dopamina para el tratamiento de la adiccion. |
| DE102004027358A1 (de) | 2004-06-04 | 2005-12-29 | Abbott Gmbh & Co. Kg | Pyrimidinverbindungen und ihre Verwendung |
| ATE452134T1 (de) * | 2004-08-09 | 2010-01-15 | Abbott Gmbh & Co Kg | Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete 4-piperazinylpyrimidinverbindungen |
| CN102887860B (zh) * | 2012-09-29 | 2015-07-01 | 上海泰坦科技有限公司 | 4-氯-6-三氟甲基嘧啶类化合物的制备方法 |
| US9598387B2 (en) | 2012-10-11 | 2017-03-21 | Southern Research Institute | Urea and amide derivatives of aminoalkylpiperazines and use thereof |
| US9376396B2 (en) | 2012-10-22 | 2016-06-28 | AbbVie Deutschland GmbH & Co. KG | Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4425143A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
-
1997
- 1997-08-14 DE DE19735410A patent/DE19735410A1/de not_active Withdrawn
-
1998
- 1998-08-12 TW TW087113230A patent/TW467912B/zh not_active IP Right Cessation
- 1998-08-12 AR ARP980103980A patent/AR016605A1/es not_active Application Discontinuation
- 1998-08-13 ZA ZA9807239A patent/ZA987239B/xx unknown
- 1998-08-13 CO CO98046527A patent/CO4960663A1/es unknown
- 1998-08-14 KR KR1020007001435A patent/KR100571945B1/ko not_active IP Right Cessation
- 1998-08-14 WO PCT/EP1998/005178 patent/WO1999009015A1/de not_active Application Discontinuation
- 1998-08-14 BR BR9811177-9A patent/BR9811177A/pt not_active IP Right Cessation
- 1998-08-14 ES ES98946343T patent/ES2374156T3/es not_active Expired - Lifetime
- 1998-08-14 AT AT98946343T patent/ATE525362T1/de active
- 1998-08-14 IL IL13424698A patent/IL134246A/en not_active IP Right Cessation
- 1998-08-14 SK SK118-2000A patent/SK1182000A3/sk unknown
- 1998-08-14 CN CN98808156A patent/CN1267286A/zh active Pending
- 1998-08-14 EP EP98946343A patent/EP1003728B1/de not_active Expired - Lifetime
- 1998-08-14 US US09/485,460 patent/US20010020022A1/en not_active Abandoned
- 1998-08-14 EP EP10179278A patent/EP2272833A1/de not_active Withdrawn
- 1998-08-14 NZ NZ502675A patent/NZ502675A/en not_active IP Right Cessation
- 1998-08-14 ID IDW20000266A patent/ID24639A/id unknown
- 1998-08-14 HU HU0003710A patent/HUP0003710A3/hu unknown
- 1998-08-14 CA CA002301297A patent/CA2301297A1/en not_active Abandoned
- 1998-08-14 AU AU93426/98A patent/AU749575B2/en not_active Ceased
- 1998-08-14 JP JP2000509698A patent/JP4444492B2/ja not_active Expired - Lifetime
- 1998-08-14 TR TR2000/00406T patent/TR200000406T2/xx unknown
- 1998-08-14 PL PL338603A patent/PL201927B1/pl unknown
-
2000
- 2000-02-03 BG BG104122A patent/BG104122A/xx unknown
- 2000-02-10 NO NO20000665A patent/NO314935B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001515070A (ja) | 2001-09-18 |
| HUP0003710A2 (hu) | 2001-10-28 |
| ID24639A (id) | 2000-07-27 |
| EP1003728A1 (de) | 2000-05-31 |
| BR9811177A (pt) | 2000-07-25 |
| WO1999009015A1 (de) | 1999-02-25 |
| PL338603A1 (en) | 2000-11-06 |
| NO20000665L (no) | 2000-02-10 |
| NO20000665D0 (no) | 2000-02-10 |
| AU9342698A (en) | 1999-03-08 |
| EP1003728B1 (de) | 2011-09-21 |
| SK1182000A3 (en) | 2000-09-12 |
| CA2301297A1 (en) | 1999-02-25 |
| AR016605A1 (es) | 2001-07-25 |
| AU749575B2 (en) | 2002-06-27 |
| DE19735410A1 (de) | 1999-02-18 |
| KR100571945B1 (ko) | 2006-04-18 |
| CO4960663A1 (es) | 2000-09-25 |
| ZA987239B (en) | 2000-02-14 |
| IL134246A0 (en) | 2001-04-30 |
| IL134246A (en) | 2002-11-10 |
| NO314935B1 (no) | 2003-06-16 |
| CN1267286A (zh) | 2000-09-20 |
| JP4444492B2 (ja) | 2010-03-31 |
| TR200000406T2 (tr) | 2000-05-22 |
| HUP0003710A3 (en) | 2002-01-28 |
| KR20010022833A (ko) | 2001-03-26 |
| NZ502675A (en) | 2001-06-29 |
| EP2272833A1 (de) | 2011-01-12 |
| TW467912B (en) | 2001-12-11 |
| PL201927B1 (pl) | 2009-05-29 |
| US20010020022A1 (en) | 2001-09-06 |
| ES2374156T3 (es) | 2012-02-14 |
| ATE525362T1 (de) | 2011-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1024232A1 (en) | Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl)piperazines | |
| GR3034969T3 (en) | N-(aroyl)glycine hydroxamic acid derivatives and related compounds | |
| CA2296604A1 (en) | Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use | |
| TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
| MY114389A (en) | Aqueous risperidone formulations | |
| MY153718A (en) | Formulation of human antibodies for treating tnf-(?) associated disorders | |
| IL142011A0 (en) | Stable concentrated insulin preparations for pulmonary delivery | |
| CA2004747A1 (en) | Substituted phenylpyrimidines useful in the treatment of cns disorders | |
| WO2002000209A3 (en) | Gabapentin analogues for sleep disorders | |
| HRP20010584B1 (en) | N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance | |
| AU1562988A (en) | DNA clone of human thrombomodulin | |
| TW223061B (en) | 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2h,5h)-acridinedione and pharmaceutical compositions containing same | |
| BG104122A (en) | 2-{3-[4-(2-tret.-butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1 -yl]propylmercapto}pyrimidin-4-ol fumarate | |
| WO2003031447A3 (de) | Pyrimidinderivate mit pde-v hemmender wirkung | |
| ZA89389B (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| IT1222395B (it) | Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare | |
| ES2108595A1 (es) | Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion. | |
| MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
| MXPA04005129A (es) | Uso de diamina de acido piridin-2,4-dicarboxilico y de diaminas de acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de la colagenasa. | |
| MX9701996A (es) | Utlizacion de 3-oxo de 2, 4-diamino-pirimidina o una de sus sales en el tratamiento de desordenes dela maduracion y de la estructuracion del colageno. | |
| PL319405A1 (en) | Derivatives of quinoxaline useful in therapy | |
| TW349864B (en) | Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders | |
| HUP9904030A2 (hu) | Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására | |
| GB0112494D0 (en) | New therapeutic use | |
| ATE44875T1 (de) | 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln. |